287 related articles for article (PubMed ID: 32841918)
21. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
22. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
25. [Lacosamide (vimpat). Prospects for clinical application].
Rudakova IG; Vlasov PN; Lipatova LV; Voronkova KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):147-152. PubMed ID: 29053136
[TBL] [Abstract][Full Text] [Related]
26. Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine.
Meador KJ; Loring DW; Boyd A; Echauz J; LaRoche S; Velez-Ruiz N; Korb P; Byrnes W; Dilley D; Borghs S; De Backer M; Story T; Dedeken P; Webster E
Epilepsy Behav; 2016 Sep; 62():267-75. PubMed ID: 27517350
[TBL] [Abstract][Full Text] [Related]
27. Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study.
Casciato S; Quarato PP; Gialluisi A; D'Aniello A; Mascia A; Grammaldo LG; Di Gennaro G
Epilepsy Behav; 2021 Sep; 122():108128. PubMed ID: 34229159
[TBL] [Abstract][Full Text] [Related]
28. Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model.
Wu T; Ido K; Ohgoh M; Hanada T
Epilepsy Res; 2019 Aug; 154():42-49. PubMed ID: 31035244
[TBL] [Abstract][Full Text] [Related]
29. Loss of β1 accessory Na+ channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high-frequency firing via differential effects on persistent Na+ currents.
Uebachs M; Albus C; Opitz T; Isom L; Niespodziany I; Wolff C; Beck H
Epilepsia; 2012 Nov; 53(11):1959-67. PubMed ID: 23016711
[TBL] [Abstract][Full Text] [Related]
30. Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis.
Lattanzi S; Trinka E; Del Giovane C; Nardone R; Silvestrini M; Brigo F
Epilepsia; 2019 Nov; 60(11):2245-2254. PubMed ID: 31608438
[TBL] [Abstract][Full Text] [Related]
31. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
[TBL] [Abstract][Full Text] [Related]
32. Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine.
Liguori C; Izzi F; Manfredi N; Mercuri NB; Placidi F
Epilepsy Behav Case Rep; 2018; 10():35-37. PubMed ID: 29977793
[TBL] [Abstract][Full Text] [Related]
33. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
Kalilani L; Halpern R; Seare J; Dedeken P
Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
[TBL] [Abstract][Full Text] [Related]
34. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
[TBL] [Abstract][Full Text] [Related]
35. Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
Shibata M; Hoshino R; Shimizu C; Sato M; Furuta N; Ikeda Y
BMC Neurol; 2021 Jun; 21(1):217. PubMed ID: 34102997
[TBL] [Abstract][Full Text] [Related]
36. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
[TBL] [Abstract][Full Text] [Related]
37. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
[TBL] [Abstract][Full Text] [Related]
38. Sodium channel blockers are effective for benign infantile epilepsy.
Numoto S; Kurahashi H; Takagi M; Azuma Y; Iwayama H; Okumura A
Seizure; 2021 Nov; 92():207-210. PubMed ID: 34592700
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers.
Suzuki T; Natsume J; Kumai S; Maki Y; Yamamoto H; Numoto S; Narahara S; Kubota T; Tsuji T; Kato T; Yamada K; Maruyama K; Okumura A; Takahashi Y; Kidokoro H
Epilepsy Behav; 2021 Dec; 125():108397. PubMed ID: 34814035
[TBL] [Abstract][Full Text] [Related]
40. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
